$2.27 Billion is the total value of Ikarian Capital, LLC's 230 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 83.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNA | Buy | MODERNA INCput | $151,482,000 | +95.7% | 1,450,000 | +32.6% | 6.68% | +19.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INCput | $148,481,000 | +99.5% | 870,900 | +64.3% | 6.55% | +21.5% |
| XBI | Buy | SPDR SER TRput | $127,843,000 | +35.0% | 908,100 | +6.8% | 5.64% | -17.8% |
| BIIB | Buy | BIOGEN INCcall | $115,181,000 | +306.0% | 470,400 | +370.4% | 5.08% | +147.3% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $89,731,000 | +34.0% | 240,000 | +20.0% | 3.96% | -18.4% |
| BIIB | Buy | BIOGEN INCput | $88,148,000 | +123.9% | 360,000 | +159.4% | 3.89% | +36.4% |
| SRPT | Buy | SAREPTA THERAPEUTICS INCcall | $85,416,000 | +492.9% | 501,000 | +388.3% | 3.77% | +261.1% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB Lcall | $71,485,000 | +138.1% | 977,200 | +152.8% | 3.15% | +45.1% |
| ARGX | Buy | ARGENX SEput | $59,260,000 | +28254.1% | 201,500 | +25087.5% | 2.61% | +17320.0% |
| ARKG | New | ARK ETF TRput | $41,044,000 | – | 440,100 | +100.0% | 1.81% | – |
| NVAX | Sell | NOVAVAX INCput | $36,097,000 | -11.3% | 323,700 | -13.8% | 1.59% | -45.9% |
| TCON | Buy | TRACON PHARMACEUTICALS INC | $31,787,000 | +184.3% | 2,716,840 | +25.6% | 1.40% | +73.3% |
| CCXI | New | CHEMOCENTRYX INCput | $27,969,000 | – | 451,700 | +100.0% | 1.23% | – |
| ZYME | Buy | ZYMEWORKS INCput | $27,422,000 | +140.2% | 580,200 | +136.8% | 1.21% | +46.4% |
| BNTX | New | BIONTECH SEput | $26,080,000 | – | 319,900 | +100.0% | 1.15% | – |
| BGNE | New | BEIGENE LTDput | $25,141,000 | – | 97,300 | +100.0% | 1.11% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $23,915,000 | +9.7% | 1,364,990 | -7.1% | 1.05% | -33.2% |
| IGMS | Sell | IGM BIOSCIENCES INCput | $22,073,000 | -4.5% | 250,000 | -20.2% | 0.97% | -41.8% |
| CVAC | New | CUREVAC N Vput | $21,175,000 | – | 261,200 | +100.0% | 0.93% | – |
| RETA | Buy | REATA PHARMACEUTICALS INCput | $20,596,000 | +268.3% | 166,600 | +190.2% | 0.91% | +124.2% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $20,204,000 | +29.9% | 1,063,961 | -13.9% | 0.89% | -20.9% |
| ARVN | Buy | ARVINAS INCcall | $19,763,000 | +424.1% | 232,700 | +45.7% | 0.87% | +219.0% |
| HZNP | New | HORIZON THERAPEUTICS PUB Lput | $19,385,000 | – | 265,000 | +100.0% | 0.86% | – |
| BEAM | New | BEAM THERAPEUTICS INCput | $18,858,000 | – | 231,000 | +100.0% | 0.83% | – |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $17,890,000 | +196.8% | 288,400 | +188.4% | 0.79% | +81.0% |
| ZYME | Sell | ZYMEWORKS INCcall | $17,732,000 | -23.9% | 375,200 | -25.0% | 0.78% | -53.6% |
| CRSP | CRISPR THERAPEUTICS AGput | $17,654,000 | +83.1% | 115,300 | 0.0% | 0.78% | +11.5% | |
| AZN | New | ASTRAZENECA PLCcall | $17,498,000 | – | 350,000 | +100.0% | 0.77% | – |
| GILD | New | GILEAD SCIENCES INCcall | $17,478,000 | – | 300,000 | +100.0% | 0.77% | – |
| ZGNX | Sell | ZOGENIX INCcall | $17,342,000 | +7.5% | 867,400 | -3.6% | 0.76% | -34.5% |
| MORF | New | MORPHIC HLDG INC | $17,338,000 | – | 516,763 | +100.0% | 0.76% | – |
| LLY | New | LILLY ELI & COcall | $16,884,000 | – | 100,000 | +100.0% | 0.74% | – |
| IONS | New | IONIS PHARMACEUTICALS INCcall | $16,397,000 | – | 290,000 | +100.0% | 0.72% | – |
| TARA | Sell | PROTARA THERAPEUTICS INC | $15,725,000 | +29.3% | 649,542 | -10.1% | 0.69% | -21.2% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INput | $15,346,000 | – | 200,000 | +100.0% | 0.68% | – |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $14,526,000 | – | 87,090 | +100.0% | 0.64% | – |
| PRTA | New | PROTHENA CORP PLC | $14,252,000 | – | 1,186,700 | +100.0% | 0.63% | – |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $14,171,000 | +8.5% | 684,573 | -60.1% | 0.62% | -33.9% |
| BPMC | New | BLUEPRINT MEDICINES CORPput | $13,457,000 | – | 120,000 | +100.0% | 0.59% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $13,360,000 | +172.4% | 615,360 | +26.1% | 0.59% | +65.9% |
| CRIS | New | CURIS INC | $12,899,000 | – | 1,575,000 | +100.0% | 0.57% | – |
| XLRN | New | ACCELERON PHARMA INCput | $12,793,000 | – | 100,000 | +100.0% | 0.56% | – |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $12,305,000 | -3.6% | 1,836,545 | +5.3% | 0.54% | -41.2% |
| KRTX | New | KARUNA THERAPEUTICS INCcall | $12,192,000 | – | 120,000 | +100.0% | 0.54% | – |
| VINC | New | VINCERA PHARMA INC | $11,265,000 | – | 538,684 | +100.0% | 0.50% | – |
| FGEN | Buy | FIBROGEN INCcall | $11,126,000 | +35.3% | 300,000 | +50.0% | 0.49% | -17.5% |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $10,981,000 | – | 50,000 | +100.0% | 0.48% | – |
| CYRX | Sell | CRYOPORT INCcall | $10,970,000 | -15.2% | 250,000 | -8.4% | 0.48% | -48.3% |
| IMVT | Sell | IMMUNOVANT INC | $10,882,000 | -3.9% | 235,587 | -26.8% | 0.48% | -41.5% |
| UTHR | New | UNITED THERAPEUTICS CORP DELcall | $10,520,000 | – | 69,300 | +100.0% | 0.46% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $10,208,000 | – | 119,100 | +100.0% | 0.45% | – |
| GOSS | Buy | GOSSAMER BIO INC | $10,138,000 | +40.2% | 1,048,383 | +80.0% | 0.45% | -14.5% |
| XBI | New | SPDR SER TRcall | $9,855,000 | – | 70,000 | +100.0% | 0.44% | – |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $9,421,000 | -13.2% | 293,941 | -18.1% | 0.42% | -47.1% |
| MRUS | New | MERUS N V | $9,411,000 | – | 536,921 | +100.0% | 0.42% | – |
| FGEN | Buy | FIBROGEN INCput | $9,343,000 | +12.6% | 251,900 | +24.8% | 0.41% | -31.4% |
| KURA | Buy | KURA ONCOLOGY INCcall | $9,309,000 | +38.5% | 285,000 | +29.9% | 0.41% | -15.6% |
| LYRA | Buy | LYRA THERAPEUTICS INC | $9,295,000 | +114.3% | 815,364 | +110.2% | 0.41% | +30.6% |
| CMPS | New | COMPASS PATHWAYS PLCcall | $8,947,000 | – | 187,800 | +100.0% | 0.39% | – |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $8,934,000 | +44.5% | 280,989 | +16.6% | 0.39% | -11.9% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lput | $8,923,000 | – | 104,100 | +100.0% | 0.39% | – |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $8,703,000 | – | 4,485,952 | +100.0% | 0.38% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INcall | $8,663,000 | – | 200,000 | +100.0% | 0.38% | – |
| ARVN | New | ARVINAS INCput | $8,493,000 | – | 100,000 | +100.0% | 0.37% | – |
| ASND | Sell | ASCENDIS PHARMA A/Scall | $8,456,000 | -62.2% | 50,700 | -65.0% | 0.37% | -77.0% |
| MCRB | Sell | SERES THERAPEUTICS INCcall | $8,357,000 | -61.3% | 341,100 | -55.3% | 0.37% | -76.4% |
| ALLK | New | ALLAKOS INCcall | $8,218,000 | – | 58,700 | +100.0% | 0.36% | – |
| DCPH | DECIPHERA PHARMACEUTICALS INcall | $7,989,000 | +11.2% | 140,000 | 0.0% | 0.35% | -32.3% | |
| SCPH | Sell | SCPHARMACEUTICALS INC | $7,756,000 | -29.7% | 1,466,147 | -1.0% | 0.34% | -57.1% |
| CRDF | New | CARDIFF ONCOLOGY INCput | $7,517,000 | – | 417,900 | +100.0% | 0.33% | – |
| ARDX | Sell | ARDELYX INC | $7,476,000 | -7.0% | 1,155,436 | -24.5% | 0.33% | -43.3% |
| PCVX | Buy | VAXCYTE INC | $7,336,000 | +821.6% | 276,110 | +1613.9% | 0.32% | +456.9% |
| VIR | New | VIR BIOTECHNOLOGY INCput | $7,176,000 | – | 268,000 | +100.0% | 0.32% | – |
| SAGE | Buy | SAGE THERAPEUTICS INCcall | $7,069,000 | +45.8% | 81,700 | +3.0% | 0.31% | -11.1% |
| IMAB | I MABsponsored ads | $7,073,000 | +0.3% | 150,000 | 0.0% | 0.31% | -38.8% | |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEWcall | $7,008,000 | +640.8% | 400,000 | +527.0% | 0.31% | +354.4% |
| BTAI | BIOXCEL THERAPEUTICS INCcall | $6,930,000 | +6.5% | 150,000 | 0.0% | 0.31% | -35.0% | |
| IMTX | IMMATICS N.V | $6,885,000 | +1.7% | 638,094 | 0.0% | 0.30% | -38.0% | |
| ALNY | ALNYLAM PHARMACEUTICALS INCput | $6,499,000 | -10.7% | 50,000 | 0.0% | 0.29% | -45.5% | |
| MRNA | New | MODERNA INC | $6,483,000 | – | 62,059 | +100.0% | 0.29% | – |
| OCUL | New | OCULAR THERAPEUTIX INCcall | $6,461,000 | – | 312,100 | +100.0% | 0.28% | – |
| TCDA | Buy | TRICIDA INC | $6,055,000 | +2783.3% | 858,908 | +3603.3% | 0.27% | +1680.0% |
| SLDB | SOLID BIOSCIENCES INC | $5,973,000 | +273.3% | 788,008 | 0.0% | 0.26% | +126.7% | |
| CMRX | Sell | CHIMERIX INC | $5,953,000 | +75.2% | 1,232,513 | -9.6% | 0.26% | +6.5% |
| SBBP | Sell | STRONGBRIDGE BIOPHARMA PLC | $5,929,000 | -16.0% | 2,440,028 | -27.4% | 0.26% | -48.9% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $5,723,000 | -19.4% | 66,151 | -43.0% | 0.25% | -51.0% |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $5,680,000 | – | 117,059 | +100.0% | 0.25% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INCcall | $5,416,000 | – | 125,000 | +100.0% | 0.24% | – |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $5,363,000 | – | 505,000 | +100.0% | 0.24% | – |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $5,314,000 | +8.3% | 826,424 | +14.0% | 0.23% | -34.1% |
| TGTX | New | TG THERAPEUTICS INCput | $5,202,000 | – | 100,000 | +100.0% | 0.23% | – |
| FULC | New | FULCRUM THERAPEUTICS INC | $5,125,000 | – | 437,700 | +100.0% | 0.23% | – |
| SRRA | Buy | SIERRA ONCOLOGY INC | $5,111,000 | +52.6% | 318,890 | +1.6% | 0.22% | -7.0% |
| ONCT | New | ONCTERNAL THERAPEUTICS INC | $5,048,000 | – | 1,030,323 | +100.0% | 0.22% | – |
| CCCC | New | C4 THERAPEUTICS INC | $5,019,000 | – | 151,500 | +100.0% | 0.22% | – |
| VSTM | Buy | VERASTEM INC | $4,802,000 | +180.8% | 2,254,591 | +59.5% | 0.21% | +71.0% |
| CYTK | Buy | CYTOKINETICS INC | $4,718,000 | +296.5% | 227,000 | +312.7% | 0.21% | +141.9% |
| CRTX | Buy | CORTEXYME INCput | $4,722,000 | +3048.0% | 170,000 | +5566.7% | 0.21% | +1790.9% |
| BLUE | New | BLUEBIRD BIO INCcall | $4,595,000 | – | 106,200 | +100.0% | 0.20% | – |
| CARA | Buy | CARA THERAPEUTICS INCcall | $4,565,000 | +518.6% | 301,700 | +420.2% | 0.20% | +279.2% |
| QDEL | New | QUIDEL CORPcall | $4,545,000 | – | 25,300 | +100.0% | 0.20% | – |
| APLT | New | APPLIED THERAPEUTICS INCput | $4,402,000 | – | 200,000 | +100.0% | 0.19% | – |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGSput | $4,338,000 | – | 100,000 | +100.0% | 0.19% | – |
| CHAQU | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $4,236,000 | +0.4% | 400,000 | 0.0% | 0.19% | -38.7% | |
| DMAC | DIAMEDICA THERAPEUTICS INC | $4,208,000 | +139.2% | 415,000 | 0.0% | 0.19% | +46.5% | |
| CRIS | New | CURIS INCcall | $4,198,000 | – | 512,500 | +100.0% | 0.18% | – |
| CARA | CARA THERAPEUTICS INC | $4,137,000 | +18.8% | 273,524 | 0.0% | 0.18% | -27.8% | |
| ANAB | New | ANAPTYSBIO INCcall | $3,915,000 | – | 182,100 | +100.0% | 0.17% | – |
| KDMN | KADMON HLDGS INC | $3,887,000 | +5.8% | 936,615 | 0.0% | 0.17% | -35.7% | |
| FSDC | New | FS DEV CORP | $3,850,000 | – | 350,000 | +100.0% | 0.17% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $3,757,000 | – | 121,486 | +100.0% | 0.17% | – |
| INMB | New | INMUNE BIO INC | $3,747,000 | – | 217,568 | +100.0% | 0.16% | – |
| CASI | Sell | CASI PHARMACEUTICALS INC | $3,741,000 | +58.8% | 1,268,154 | -17.6% | 0.16% | -3.5% |
| GOSS | Buy | GOSSAMER BIO INCcall | $3,688,000 | +265.5% | 381,300 | +369.0% | 0.16% | +123.3% |
| FATE | Sell | FATE THERAPEUTICS INCput | $3,529,000 | +76.2% | 38,800 | -22.6% | 0.16% | +7.6% |
| FATE | Sell | FATE THERAPEUTICS INCcall | $3,500,000 | +74.7% | 38,500 | -23.2% | 0.15% | +6.2% |
| PASG | New | PASSAGE BIO INC | $3,495,000 | – | 136,697 | +100.0% | 0.15% | – |
| ZGNX | Sell | ZOGENIX INC | $3,480,000 | +6.3% | 174,091 | -4.7% | 0.15% | -35.4% |
| XENE | XENON PHARMACEUTICALS INC | $3,432,000 | +38.9% | 223,173 | 0.0% | 0.15% | -15.6% | |
| STTK | New | SHATTUCK LABS INC | $3,406,000 | – | 65,000 | +100.0% | 0.15% | – |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $3,321,000 | – | 100,000 | +100.0% | 0.15% | – |
| ARNA | Sell | ARENA PHARMACEUTICALS INCcall | $3,265,000 | -83.2% | 42,500 | -83.7% | 0.14% | -89.8% |
| CHMA | Sell | CHIASMA INC | $3,177,000 | -54.7% | 730,299 | -55.2% | 0.14% | -72.4% |
| ITCI | INTRA CELLULAR THERAPIES INCput | $3,180,000 | +23.9% | 100,000 | 0.0% | 0.14% | -24.7% | |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $3,134,000 | – | 140,913 | +100.0% | 0.14% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INCcall | $3,121,000 | +33.8% | 650,000 | +62.5% | 0.14% | -18.3% |
| CYTK | Sell | CYTOKINETICS INCcall | $3,116,000 | -87.7% | 150,000 | -87.2% | 0.14% | -92.5% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $3,082,000 | -30.1% | 642,108 | -15.1% | 0.14% | -57.4% |
| CYCC | New | CYCLACEL PHARMACEUTICALS INC | $3,057,000 | – | 391,450 | +100.0% | 0.14% | – |
| FREQ | New | FREQUENCY THERAPEUTICS INCput | $3,028,000 | – | 85,900 | +100.0% | 0.13% | – |
| AGEN | AGENUS INC | $3,020,000 | -20.5% | 950,000 | 0.0% | 0.13% | -51.6% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $2,995,000 | +29.7% | 56,008 | 0.0% | 0.13% | -21.0% | |
| New | TRILLIUM THERAPEUTICS INCcall | $2,942,000 | – | 200,000 | +100.0% | 0.13% | – | |
| MRSN | New | MERSANA THERAPEUTICS INC | $2,820,000 | – | 106,000 | +100.0% | 0.12% | – |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INCcall | $2,804,000 | -32.5% | 258,700 | -35.9% | 0.12% | -58.8% |
| LQDA | New | LIQUIDIA CORPORATION | $2,807,000 | – | 951,400 | +100.0% | 0.12% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INCcall | $2,761,000 | – | 145,500 | +100.0% | 0.12% | – |
| PSTX | Buy | POSEIDA THERAPEUTICS INC | $2,752,000 | +36.1% | 250,837 | +10.0% | 0.12% | -17.1% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $2,630,000 | -6.4% | 23,654 | 0.0% | 0.12% | -42.9% | |
| ICAD | Buy | ICAD INC | $2,576,000 | +61.4% | 195,137 | +7.6% | 0.11% | -1.7% |
| NKTR | NEKTAR THERAPEUTICScall | $2,550,000 | +2.5% | 150,000 | 0.0% | 0.11% | -37.8% | |
| IPOC | New | SOCIAL CAP HEDSPIA HLDG CO Icall | $2,516,000 | – | 150,000 | +100.0% | 0.11% | – |
| ACET | Sell | ADICET BIO INC | $2,449,000 | -24.9% | 174,277 | -36.5% | 0.11% | -54.2% |
| PANA | New | PANACEA ACQUISITION CORPcl a | $2,361,000 | – | 201,808 | +100.0% | 0.10% | – |
| ACHIEVE LIFE SCIENCES INC | $2,302,000 | -3.2% | 284,151 | 0.0% | 0.10% | -41.3% | ||
| NBIX | New | NEUROCRINE BIOSCIENCES INCcall | $2,272,000 | – | 23,700 | +100.0% | 0.10% | – |
| YMTX | New | YUMANITY THERAPEUTICS INC | $2,253,000 | – | 132,514 | +100.0% | 0.10% | – |
| AGTC | APPLIED GENETIC TECHNOLOGIES | $2,232,000 | -15.9% | 545,884 | 0.0% | 0.10% | -49.0% | |
| SNDX | New | SYNDAX PHARMACEUTICALS INCcall | $2,224,000 | – | 100,000 | +100.0% | 0.10% | – |
| CYRX | Sell | CRYOPORT INCput | $2,195,000 | -81.5% | 50,000 | -80.0% | 0.10% | -88.7% |
| GWPH | New | GW PHARMACEUTICALS PLCput | $2,204,000 | – | 19,100 | +100.0% | 0.10% | – |
| NXTC | NEXTCURE INC | $2,179,000 | +23.8% | 200,000 | 0.0% | 0.10% | -24.4% | |
| ANAB | Buy | ANAPTYSBIO INC | $2,149,000 | +191.2% | 100,000 | +100.0% | 0.10% | +79.2% |
| HROW | Sell | HARROW HEALTH INC | $2,117,000 | -17.4% | 308,607 | -32.7% | 0.09% | -49.7% |
| DCTH | Buy | DELCATH SYS INC | $2,019,000 | +84.9% | 112,712 | +19.9% | 0.09% | +12.7% |
| MBIO | Sell | MUSTANG BIO INC | $1,991,000 | -21.6% | 526,003 | -34.8% | 0.09% | -52.2% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $1,941,000 | – | 300,000 | +100.0% | 0.09% | – |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $1,897,000 | +218.3% | 358,330 | +117.5% | 0.08% | +95.3% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INCcall | $1,846,000 | -71.2% | 58,000 | -76.8% | 0.08% | -82.5% |
| KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $1,789,000 | -65.9% | 101,273 | -70.5% | 0.08% | -79.2% |
| New | BELLICUM PHARMACEUTICALS INC | $1,765,000 | – | 500,000 | +100.0% | 0.08% | – | |
| BCTG | Buy | BCTG ACQUISITION CORP | $1,711,000 | +85450.0% | 149,512 | +59704.8% | 0.08% | – |
| OTIC | Sell | OTONOMY INC | $1,678,000 | -4.7% | 259,337 | -40.4% | 0.07% | -41.7% |
| IPOC | New | SOCIAL CAP HEDSPIA HLDG CO I | $1,677,000 | – | 100,000 | +100.0% | 0.07% | – |
| LIFE | New | ATYR PHARMA INC | $1,552,000 | – | 400,000 | +100.0% | 0.07% | – |
| ACRS | New | ACLARIS THERAPEUTICS INCcall | $1,527,000 | – | 235,800 | +100.0% | 0.07% | – |
| BIIB | Buy | BIOGEN INC | $1,396,000 | +63.8% | 5,700 | +90.0% | 0.06% | 0.0% |
| AUPH | AURINIA PHARMACEUTICALS INCcall | $1,383,000 | -6.2% | 100,000 | 0.0% | 0.06% | -43.0% | |
| New | CATABASIS PHARMACEUTICALS IN | $1,392,000 | – | 650,000 | +100.0% | 0.06% | – | |
| GMDA | New | GAMIDA CELL LTD | $1,343,000 | – | 160,000 | +100.0% | 0.06% | – |
| LGVW | New | LONGVIEW ACQUISITION CORP | $1,243,000 | – | 62,796 | +100.0% | 0.06% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,209,000 | -27.5% | 345,529 | -50.3% | 0.05% | -56.2% |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $1,127,000 | -78.9% | 23,648 | -84.5% | 0.05% | -87.1% |
| FIXX | New | HOMOLOGY MEDICINES INCput | $1,129,000 | – | 100,000 | +100.0% | 0.05% | – |
| SYRS | New | SYROS PHARMACEUTICALS INC | $1,085,000 | – | 100,000 | +100.0% | 0.05% | – |
| CEMI | New | CHEMBIO DIAGNOSTICS INC | $1,041,000 | – | 219,109 | +100.0% | 0.05% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INCcall | $1,026,000 | – | 100,000 | +100.0% | 0.04% | – |
| CYRX | New | CRYOPORT INC | $1,004,000 | – | 22,900 | +100.0% | 0.04% | – |
| ALEC | Buy | ALECTOR INC | $870,000 | +28900.0% | 57,500 | +17812.8% | 0.04% | – |
| ALT | Sell | ALTIMMUNE INC | $851,000 | -43.3% | 75,445 | -33.7% | 0.04% | -65.1% |
| ETNB | Sell | 89BIO INC | $799,000 | -90.8% | 32,799 | -90.4% | 0.04% | -94.5% |
| CRTX | Buy | CORTEXYME INCcall | $776,000 | +417.3% | 28,000 | +833.3% | 0.03% | +209.1% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $781,000 | -87.8% | 3,557 | -90.8% | 0.03% | -92.7% |
| IFRX | INFLARX NV | $754,000 | +18.4% | 149,750 | 0.0% | 0.03% | -28.3% | |
| APLT | New | APPLIED THERAPEUTICS INC | $726,000 | – | 33,002 | +100.0% | 0.03% | – |
| ALBO | New | ALBIREO PHARMA INC | $633,000 | – | 16,883 | +100.0% | 0.03% | – |
| KALA | Sell | KALA PHARMACEUTICALS INC | $594,000 | -82.5% | 87,813 | -80.6% | 0.03% | -89.4% |
| PBYI | PUMA BIOTECHNOLOGY INC | $563,000 | +1.6% | 54,901 | 0.0% | 0.02% | -37.5% | |
| CERC | CERECOR INC | $536,000 | +16.5% | 202,865 | 0.0% | 0.02% | -27.3% | |
| RCUS | New | ARCUS BIOSCIENCES INCput | $532,000 | – | 20,500 | +100.0% | 0.02% | – |
| COGT | New | COGENT BIOSCIENCES INC | $469,000 | – | 41,762 | +100.0% | 0.02% | – |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INCput | $486,000 | -84.0% | 44,800 | -84.8% | 0.02% | -90.5% |
| ARPO | Sell | AERPIO PHARMACEUTICALS INC | $468,000 | -92.1% | 475,778 | -87.9% | 0.02% | -95.1% |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $444,000 | -89.0% | 644,021 | -64.2% | 0.02% | -93.2% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $439,000 | -83.0% | 72,468 | -54.0% | 0.02% | -89.8% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $416,000 | -39.5% | 1,146,308 | -4.2% | 0.02% | -64.0% |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $405,000 | – | 2,006,451 | +100.0% | 0.02% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $398,000 | – | 200,000 | +100.0% | 0.02% | – |
| ABUS | ARBUTUS BIOPHARMA CORP | $408,000 | +13.3% | 115,000 | 0.0% | 0.02% | -30.8% | |
| KURA | Buy | KURA ONCOLOGY INC | $366,000 | +93.7% | 11,203 | +80.6% | 0.02% | +14.3% |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $366,000 | +33.1% | 54,694 | 0.0% | 0.02% | -20.0% | |
| ARVN | New | ARVINAS INC | $358,000 | – | 4,216 | +100.0% | 0.02% | – |
| CRTX | Sell | CORTEXYME INC | $361,000 | -82.0% | 13,000 | -67.5% | 0.02% | -89.0% |
| RAPT | RAPT THERAPEUTICS INCput | $309,000 | -38.6% | 15,600 | 0.0% | 0.01% | -61.1% | |
| BLU | BELLUS HEALTH INC NEW | $306,000 | +34.8% | 100,000 | 0.0% | 0.01% | -18.8% | |
| MLND | MILLENDO THERAPEUTICS INC | $289,000 | +31.4% | 135,193 | 0.0% | 0.01% | -18.8% | |
| NVAX | NOVAVAX INC | $294,000 | +2.8% | 2,636 | 0.0% | 0.01% | -38.1% | |
| INBX | New | INHIBRX INC | $266,000 | – | 8,076 | +100.0% | 0.01% | – |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $275,000 | – | 5,000 | +100.0% | 0.01% | – |
| SLNO | New | SOLENO THERAPEUTICS INC | $236,000 | – | 122,462 | +100.0% | 0.01% | – |
| IVA | INVENTIVA SAads | $214,000 | +20.9% | 15,000 | 0.0% | 0.01% | -30.8% | |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGS | $174,000 | – | 139,100 | +100.0% | 0.01% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INCcall | $119,000 | – | 17,900 | +100.0% | 0.01% | – |
| BXRX | BAUDAX BIO INC | $101,000 | -63.5% | 100,000 | 0.0% | 0.00% | -80.0% | |
| GBT | GLOBAL BLOOD THERAPEUTICS INput | $91,000 | -22.2% | 2,100 | 0.0% | 0.00% | -50.0% | |
| ZYME | New | ZYMEWORKS INC | $73,000 | – | 1,556 | +100.0% | 0.00% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $75,000 | – | 1,400 | +100.0% | 0.00% | – |
| RAPT | Sell | RAPT THERAPEUTICS INCcall | $69,000 | -59.4% | 3,500 | -34.0% | 0.00% | -75.0% |
| KNTE | New | KINNATE BIOPHARMA INC | $79,000 | – | 2,000 | +100.0% | 0.00% | – |
| MITO | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $57,000 | +14.0% | 37,597 | 0.0% | 0.00% | -25.0% | |
| TBIO | New | TRANSLATE BIO INCput | $67,000 | – | 3,600 | +100.0% | 0.00% | – |
| ALPN | ALPINE IMMUNE SCIENCES INC | $60,000 | +46.3% | 4,739 | 0.0% | 0.00% | 0.0% | |
| APTOSE BIOSCIENCES INC | $18,000 | -21.7% | 3,904 | 0.0% | 0.00% | -50.0% | ||
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $12,000 | – | 791 | +100.0% | 0.00% | – |
| IGMS | New | IGM BIOSCIENCES INC | $27,000 | – | 300 | +100.0% | 0.00% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $12,000 | -99.4% | 281 | -99.3% | 0.00% | -99.4% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $0 | – | 8 | +100.0% | 0.00% | – |
| CGEN | New | COMPUGEN LTDput | $6,000 | – | 500 | +100.0% | 0.00% | – |
| CCXI | CHEMOCENTRYX INC | $2,000 | +100.0% | 37 | 0.0% | 0.00% | – | |
| BLSA | New | BCLS ACQUISITION CORP | $1,000 | – | 100 | +100.0% | 0.00% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -8,812 | -100.0% | -0.00% | – |
| OVID | Exit | OVID THERAPEUTICS INCcall | $0 | – | -16,000 | -100.0% | -0.01% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -2,714 | -100.0% | -0.01% | – |
| MESO | Exit | MESOBLAST LTDput | $0 | – | -7,800 | -100.0% | -0.01% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INCput | $0 | – | -10,000 | -100.0% | -0.01% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INCcall | $0 | – | -10,000 | -100.0% | -0.01% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -2,641 | -100.0% | -0.02% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -29,080 | -100.0% | -0.02% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -5,000 | -100.0% | -0.03% | – |
| CRBP | Exit | CORBUS PHARMACEUTICALS HLDGScall | $0 | – | -220,100 | -100.0% | -0.03% | – |
| ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -200,000 | -100.0% | -0.04% | – |
| AL | Exit | AIR LEASE CORPput | $0 | – | -17,600 | -100.0% | -0.04% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -18,726 | -100.0% | -0.04% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -50,000 | -100.0% | -0.06% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -177,684 | -100.0% | -0.06% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -16,100 | -100.0% | -0.10% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -125,000 | -100.0% | -0.12% | – |
| APTX | Exit | APTINYX INC | $0 | – | -495,490 | -100.0% | -0.12% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -2,389,891 | -100.0% | -0.19% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -95,430 | -100.0% | -0.20% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -340,318 | -100.0% | -0.20% | – |
| MYOV | Exit | MYOVANT SCIENCES LTDcall | $0 | – | -200,000 | -100.0% | -0.20% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -260,000 | -100.0% | -0.22% | – |
| LSAC | Exit | LIFESCI ACQUISITION CORP | $0 | – | -241,762 | -100.0% | -0.22% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -63,011 | -100.0% | -0.23% | – |
| ARYBU | Exit | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $0 | – | -318,206 | -100.0% | -0.25% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.30% | – |
| HST | Exit | HOST HOTELS & RESORTS INCput | $0 | – | -400,000 | -100.0% | -0.31% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS INput | $0 | – | -100,000 | -100.0% | -0.37% | – |
| CCXI | Exit | CHEMOCENTRYX INCcall | $0 | – | -100,000 | -100.0% | -0.40% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -426,800 | -100.0% | -0.40% | – |
| RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -190,410 | -100.0% | -0.42% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS INcall | $0 | – | -150,000 | -100.0% | -0.47% | – |
| CYTK | Exit | CYTOKINETICS INCput | $0 | – | -320,000 | -100.0% | -0.50% | – |
| INCY | Exit | INCYTE CORPput | $0 | – | -100,000 | -100.0% | -0.65% | – |
| MPW | Exit | MEDICAL PPTYS TRUST INCput | $0 | – | -600,000 | -100.0% | -0.77% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INCput | $0 | – | -326,500 | -100.0% | -0.81% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcall | $0 | – | -117,100 | -100.0% | -0.83% | – |
| INCY | Exit | INCYTE CORPcall | $0 | – | -150,000 | -100.0% | -0.97% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INCcall | $0 | – | -114,900 | -100.0% | -0.99% | – |
| KOD | Exit | KODIAK SCIENCES INCput | $0 | – | -250,000 | -100.0% | -1.07% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -300,000 | -100.0% | -1.31% | – |
| IGMS | Exit | IGM BIOSCIENCES INCcall | $0 | – | -250,000 | -100.0% | -1.34% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICSput | $0 | – | -1,170,100 | -100.0% | -1.43% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCput | $0 | – | -549,000 | -100.0% | -6.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.